 |
|
|
| |
Pharmacokinetics, safety and efficacy of atazanavir, dolutegravir and lamivudine as maintenance regimen in HIV-infected patients: a pilot study
|
| |
| |
A pilot study evaluating plasma and intracellular pharmacokinetics (PK) of switching from atazanavir (ATV) 400mg QD to ATV 200 mg BID in HIV+ patients......
http://www.natap.org/2008/Pharm/Pharm_19.htm
Reported by Jules Levin
Presented at 17th International Workshop on Clinical Pharmacology of HIV and Hepatitis Therapy, 2016, Washington, DC, USA
PDJ Bollen1,2, R. Van Crevel3, E.H. Gisolf4, M. van Luin5, A. Colbers1, A.E. Brouwer6 and DM Burger1
1 Department of Pharmacy & Radboud Institute for Health Sciences, Radboud university medical center, Nijmegen, The Netherlands; 2 Hospital Pharmacy Midden-Brabant, Elisabeth TweeSteden Hospital, Tilburg, The Netherlands; 3 Department of Infectious diseases, Radboud University Medical Center, Nijmegen, The Netherlands; 4 Department of Infectious diseases, Rijnstate Hospital, Arnhem, The Netherlands; 5 Department of Clinical Pharmacy, Rijnstate Hospital, Arnhem, The Netherlands; 6 Department of Infectious diseases, Elisabeth TweeSteden Hospital, Tilburg, The Netherlands.
|
| |
|
|
|
|
|
